Why vaccines may not be able to eliminate Covid-19: QuickTake

The coronavirus vaccination program is underway in Hungary

Photographer: Akos Stiller / Bloomberg

The road to elimination of Covid-19 is long and paved with uncertainty. Many countries rely on vaccines to build sufficient immunity in their populations so that SARS-CoV-2 cannot find people susceptible to infection, slowing down the transmission of coronavirus and eventually stopping it. But even with the launch of highly effective vaccines, immunization coverage may not reach this level – the so-called herd immunity threshold – anytime soon. First of all, it is it is not known what level of immunity is needed and whether there will be vaccines strong enough to touch it. There is also the threat emerging variants of coronavirus that may weaken the effectiveness of immunizations.

1. Can Covid-19 be eradicated?

Not. So far, only one human disease – smallpox – was official eradicated; ie reduced to zero cases and maintained there for a long time without continuous intervention measures. Smallpox has been eliminated due to an extremely effective vaccine and the fact that humans are the only mammals that are naturally susceptible to infection with smallpox virus that causes disfiguring, sometimes fatal, disease. People are the only known reservoir of poliovirus, but continues to spread several countries causing paralyzing diseases, despite the widespread use of effective immunizations and a 32-year-old child global eradication effort. SARS-CoV-2 is thought to persist in the horseshoe and has been known to infect minks, cats, gorillas and other animals. Deleting the virus would require its removal from all susceptible species, which is not feasible. In countries that have successfully abolished Covid-19 cases, the elimination of the disease was proposed instead.

2. What is elimination?

Then came the efforts to suppress an outbreak zero new cases of disease or infection in a defined area over a sustained period. There is no official definition of duration. One proposal is to do it 28 days, which corresponds to twice as much as the outer interval of the incubation period of SARS-CoV-2 – the time between infection and the onset of symptoms. Some countries, such as New Zealand, have obtained zero new cases for long periods of time, using border closures, blockades and case detection and isolation. During a pandemic, which is an outbreak of a new infection on the continents, supporting the elimination of any infectious disease nationwide is challenging, if not impossible, due to the threat of the virus re-entering the country by infected international travelers.

3. Will vaccines eliminate Covid-19?

It’s hard to say. It is not known what the proportion of the population must have immunity to stop the circulation of the coronavirus or if even the strongest vaccines will be able to prevent its spread. One study estimated that in order to stop transmission, 55% to 82% of the population should have immunity, which can be achieved either by recovery from an infection or by vaccination. However, the immunity of the herd it was not performed in Manaus, the capital of the Brazilian state of Amazonas, even after about 76% of the population was infected. However, there is reason to believe that mass vaccinations will have a stronger effect, as vaccines appear to achieve stronger and more lasting protection than a previous infection.

4. How effective will the vaccines be?

There is good evidence that the shootings made by Pfizer Inc.—BioNTech SE and Moderna Inc. are very effective – up to 95% – in preventing recipients from developing Covid-19 itself. However, no data have been published on their ability to prevent people from developing asymptomatic infections or transmitting the virus to others. The gold standard in vaccinology is to stop infection as well as disease by providing so-called sterilizing immunity. But it is not always achieved. The measles vaccine, for example, prevents infection so that vaccinated people do not spread the virus, while the measles vaccine Whooping cough does a good job protecting against serious illness, but is less effective at stopping the infection. Encouraging, a The study of the Coverna Moderna vaccine in monkeys suggested that it would reduce, if not completely prevent, the subsequent transmission of the virus. Clinical trials using The AstraZeneca Plc vaccine indicates that it can be less than 60% effective in stopping infections – which makes it unlikely that the population will be immune even if everyone in a population has received two doses.

5. How do virus factor variants come in?

The researchers studied the ability of antibodies in the blood of patients recovered from Covid-19 to block the new fast-spreading variants B.1.1.7, 501Y.V2 and P.1 reported for the first time in the UK, South Africa and Brazil. Some research has shown the potential of these strains to get rid of the immune protection offered by natural infection. Scientists have warned that laboratory studies are only indicative and there is no evidence that this is actually happening in the community or if the antibodies generated by the vaccine will be less effective against the new strain.

6. Should Covid-19 vaccines prevent infection to reduce cases?

.Source